BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 31883431)

  • 1. Prognostic ability of the distance-saturation product in the 6-minute walk test in patients with chronic obstructive pulmonary disease.
    Gurbani N; Figueira Gonçalves JM; García Bello MÁ; García-Talavera I; Afonso Díaz A
    Clin Respir J; 2020 Apr; 14(4):364-369. PubMed ID: 31883431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of walk distance, work, oxygen saturation, and dyspnea during 6-minute walk test in COPD patients.
    Golpe R; Pérez-de-Llano LA; Méndez-Marote L; Veres-Racamonde A
    Respir Care; 2013 Aug; 58(8):1329-34. PubMed ID: 23322886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distance-saturation product of the 6-minute walk test predicts mortality of patients with non-cystic fibrosis bronchiectasis.
    Hsieh MH; Fang YF; Chung FT; Lee CS; Chang YC; Liu YZ; Wu CH; Lin HC
    J Thorac Dis; 2017 Sep; 9(9):3168-3176. PubMed ID: 29221293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of relevant variables and construction of a multidimensional index for predicting mortality in COPD patients.
    Xu L; Ye T; Li J; Hu Y; Xu W; Wang K; Ou C; Chen X
    Int J Chron Obstruct Pulmon Dis; 2019; 14():1703-1711. PubMed ID: 31534324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Six-Minute Walk Test: Clinical Role, Technique, Coding, and Reimbursement.
    Agarwala P; Salzman SH
    Chest; 2020 Mar; 157(3):603-611. PubMed ID: 31689414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Replacement of the 6-min walk test with maximal oxygen consumption in the BODE Index applied to patients with COPD: an equivalency study.
    Cardoso F; Tufanin AT; Colucci M; Nascimento O; Jardim JR
    Chest; 2007 Aug; 132(2):477-82. PubMed ID: 17505032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The distance-saturation product predicts mortality in idiopathic pulmonary fibrosis.
    Lettieri CJ; Nathan SD; Browning RF; Barnett SD; Ahmad S; Shorr AF
    Respir Med; 2006 Oct; 100(10):1734-41. PubMed ID: 16545950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Usefulness of the 6-minute walk test as a screening test for pulmonary arterial enlargement in COPD.
    Oki Y; Kaneko M; Fujimoto Y; Sakai H; Misu S; Mitani Y; Yamaguchi T; Yasuda H; Ishikawa A
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2869-2875. PubMed ID: 27920514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic obstructive pulmonary disease in patients undergoing transcatheter aortic valve implantation: insights on clinical outcomes, prognostic markers, and functional status changes.
    Mok M; Nombela-Franco L; Dumont E; Urena M; DeLarochellière R; Doyle D; Villeneuve J; Côté M; Ribeiro HB; Allende R; Laflamme J; DeLarochellière H; Laflamme L; Amat-Santos I; Pibarot P; Maltais F; Rodés-Cabau J
    JACC Cardiovasc Interv; 2013 Oct; 6(10):1072-84. PubMed ID: 24156967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distance and oxygen desaturation during the 6-min walk test as predictors of long-term mortality in patients with COPD.
    Casanova C; Cote C; Marin JM; Pinto-Plata V; de Torres JP; Aguirre-Jaíme A; Vassaux C; Celli BR
    Chest; 2008 Oct; 134(4):746-752. PubMed ID: 18625667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of mortality in patients with COPD after 9 years.
    Prudente R; Franco EAT; Mesquita CB; Ferrari R; de Godoy I; Tanni SE
    Int J Chron Obstruct Pulmon Dis; 2018; 13():3389-3398. PubMed ID: 30410324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hand grip endurance test relates to clinical state and prognosis in COPD patients better than 6-minute walk test distance.
    Kovarik M; Joskova V; Patkova A; Koblizek V; Zadak Z; Hronek M
    Int J Chron Obstruct Pulmon Dis; 2017; 12():3429-3435. PubMed ID: 29238187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of variables derived from the six-minute walk test in patients with COPD: Results from the ECLIPSE study.
    Andrianopoulos V; Wouters EF; Pinto-Plata VM; Vanfleteren LE; Bakke PS; Franssen FM; Agusti A; MacNee W; Rennard SI; Tal-Singer R; Vogiatzis I; Vestbo J; Celli BR; Spruit MA
    Respir Med; 2015 Sep; 109(9):1138-46. PubMed ID: 26143282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of Poor Short-Term Prognosis and Unmet Needs in Advanced Chronic Obstructive Pulmonary Disease: Use of the Two-Minute Walking Distance Extracted from a Six-Minute Walk Test.
    Neo HY; Xu HY; Wu HY; Hum A
    J Palliat Med; 2017 Aug; 20(8):821-828. PubMed ID: 28353374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is the six-minute walk test a useful tool to prescribe high-intensity exercise in patients with chronic obstructive pulmonary disease?
    Rodrigues A; Di Martino M; Nellessen AG; Hernandes NA; Neder JA; Pitta F
    Heart Lung; 2016; 45(6):550-556. PubMed ID: 27639286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting mortality in non-cystic fibrosis bronchiectasis patients using distance-saturation product.
    Lin CY; Hsieh MH; Fang YF; Peng CW; Ju JS; Lo YL; Lin SM; Lin HC
    Ann Med; 2021 Dec; 53(1):2034-2040. PubMed ID: 34761709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulmonary function test results are correlated with 6-minute walk distance, distance-saturation product, and 6-minute walk work in patients with lymphangioleiomyomatosis.
    Diesler R; Cottin V; Gallien Y; Turquier S; Traclet J; Ahmad K; Glerant JC
    Respir Med Res; 2024 Jun; 85():101071. PubMed ID: 38141576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. One Year Change in 6-Minute Walk Test Outcomes is Associated with COPD Prognosis.
    Waatevik M; Frisk B; Real FG; Hardie JA; Bakke P; Nilsen RM; Eagan TM; Johannessen A
    COPD; 2020 Dec; 17(6):662-671. PubMed ID: 33164586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The 6-Minute Walk Test as a Tool for Determining Exercise Capacity and Prognosis in Patients with Silicosis.
    Blanco Pérez JJ; Arnalich Montiel V; Salgado-Barreira Á; Alvarez Moure MA; Caldera Díaz AC; Cerdeira Dominguez L; Gonzalez Bello ME; Fernandez Villar A; González Barcala FJ
    Arch Bronconeumol (Engl Ed); 2019 Feb; 55(2):88-92. PubMed ID: 30100206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The modified BODE index: validation with mortality in COPD.
    Cote CG; Pinto-Plata VM; Marin JM; Nekach H; Dordelly LJ; Celli BR
    Eur Respir J; 2008 Nov; 32(5):1269-74. PubMed ID: 18579541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.